2019
DOI: 10.1016/j.jaad.2018.08.048
|View full text |Cite
|
Sign up to set email alerts
|

Assessment of clinician accuracy for diagnosing melanoma on the basis of electrical impedance spectroscopy score plus morphology versus lesion morphology alone

Abstract: 8. Duffin KC, Yeung H, Takeshita J, et al. Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practice. Br J Dermatol. 2014;170(3):672-680. 9. Weinstein GD, Koo JY, Krueger GG, et al. Tazarotene cream in the treatment of psoriasis: two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. J Am Acad Dermatol. 2003;48(5):760-767. 10. Gupta SK, Singh KK, Lalit M. Compar… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
26
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(28 citation statements)
references
References 6 publications
0
26
0
Order By: Relevance
“…
Early recognition and treatment of melanoma positively impacts outcomes and healthcare costs. [1][2][3][4] Significant heterogeneity exists with clinicians' ability to correctly assess the severity of pigmented lesions, leading to missed melanomas and unnecessary biopsies. 5 The number-ABSTRACT Introduction: The number-needed-to-biopsy (NNB) metric measures the efficiency of a clinician's ability to accurately diagnose and recommend pigmented skin lesions (PSLs) for biopsy for suspected melanomas.
…”
mentioning
confidence: 99%
“…
Early recognition and treatment of melanoma positively impacts outcomes and healthcare costs. [1][2][3][4] Significant heterogeneity exists with clinicians' ability to correctly assess the severity of pigmented lesions, leading to missed melanomas and unnecessary biopsies. 5 The number-ABSTRACT Introduction: The number-needed-to-biopsy (NNB) metric measures the efficiency of a clinician's ability to accurately diagnose and recommend pigmented skin lesions (PSLs) for biopsy for suspected melanomas.
…”
mentioning
confidence: 99%
“…Higher scores indicate altered bioimpedance compared to within-patient control sites (11). EIS led to a change in a decision to biopsy lesions in 25% of cases, improved diagnostic accuracy, led to fewer biopsies of benign lesions and more biopsies of malignant lesions (54). It is currently unclear if EIS demonstrates altered signals in lesional HS tissue.…”
Section: Resultsmentioning
confidence: 99%
“…EIS studies employed the commercially-available Nevisense with a dedicated scoring system (57,58). However, it is unclear how this score is assigned to the investigated lesion, furthermore, most of the misdiagnosis were done on early-stage melanomas (58,63). A limitation of this technique is the need to take multiple measures of the same lesion, as the instrument's electrodes area does not cover the entire lesion.…”
Section: Discussionmentioning
confidence: 99%
“…For the EIS measurements, the majority of the studies employed the Nevisense system (56-60, 62, 63) (SCIBASE AB, Stockholm, Sweden), while only one study (61) used the Dermasense system. Three studies used the Nevisense to understand its efficacy (58,62,63) and safety (58), comparing the diagnostic performance of its decisional score system with the ABCD rule and the 7-point checklist. Gilou et al ( 61) collected only two measurements on one melanoma among their data.…”
Section: Skin Electrical Measurementsmentioning
confidence: 99%
See 1 more Smart Citation